Download Full eBooks in PDF
Public Health Preparedness Developing And Acquiring Medical Countermeasures Against Chemical Biological Radiological And Nuclear Agents Book in PDF, ePub and Kindle version is available to download in english. Read online anytime anywhere directly from your device. Click on the download button below to get a free pdf file of Public Health Preparedness Developing And Acquiring Medical Countermeasures Against Chemical Biological Radiological And Nuclear Agents book. This book definitely worth reading, it is an incredibly well-written.
Author : United States Government Accountability Office
Publisher : Createspace Independent Publishing Platform
Page : 34 pages
File Size : 41,7 Mb
Release : 2018-05-14
Category : Electronic
ISBN : 1719072663
Public Health Preparedness: Developing and Acquiring Medical Countermeasures Against Chemical, Biological, Radiological, and Nuclear Agents
Author : Anonim
Publisher : DIANE Publishing
Page : 19 pages
File Size : 41,8 Mb
Release : 2024-04-30
Category : Electronic
ISBN : 9781437984699
Author : HHS Public Health Emergency Medical Countermeasures Enterprise (U.S.)
Publisher : Unknown
Page : 44 pages
File Size : 46,9 Mb
Release : 2007
Category : Disaster medicine
ISBN : UOM:39015075641509
Author : Anna J. Clemens,Marcel P. Nielsen
Publisher : Unknown
Page : 0 pages
File Size : 40,8 Mb
Release : 2012
Category : Bioterrorism
ISBN : 161942519X
The United States remains vulnerable to terrorist and other threats posed by chemical, biological, radiological, and nuclear (CBRN) agents. Medical countermeasures such as drugs, vaccines, and diagnostic devices, can prevent or treat the effects of exposure, but few are currently available. This book examines the federal efforts needed to develop and acquire countermeasures to threats from terrorists and other sources, primarily through the Public Health Emergency Medical Countermeasures Enterprise (PHEMCE).
Author : United States. Government Accountability Office
Publisher : Unknown
Page : 52 pages
File Size : 41,7 Mb
Release : 2011
Category : Emergency management
ISBN : OCLC:1037530271
The United States remains vulnerable to terrorist and other threats posed by chemical, biological, radiological, and nuclear (CBRN) agents. Medical countermeasures -- drugs, vaccines, and diagnostic devices -- can prevent or treat the effects of exposure, but few are currently available. The Department of Health and Human Services (HHS) leads federal efforts to develop and acquire countermeasures, primarily through the Public Health Emergency Medical Countermeasures Enterprise (PHEMCE), an interagency body. This report examines the extent to which HHS (1) based its priorities for developing and acquiring countermeasures on CBRN risk assessments; (2) addressed its own recommendations to improve acquisition and development; and (3) coordinated internally for these efforts. GAO reviewed relevant laws, agency documents, CBRN risk assessments, and reports from outside experts; interviewed HHS and industry officials; and analyzed HHS funding for CBRN countermeasures from fiscal years 2007 through 2010.
Author : Institute of Medicine,Board on Health Sciences Policy,Forum on Medical and Public Health Preparedness for Catastrophic Events,Forum on Drug Discovery, Development, and Translation
Publisher : National Academies Press
Page : 150 pages
File Size : 53,9 Mb
Release : 2011-08-27
Category : Medical
ISBN : 9780309214902
Whether or not the United States has safe and effective medical countermeasures-such as vaccines, drugs, and diagnostic tools-available for use during a disaster can mean the difference between life and death for many Americans. The Food and Drug Administration (FDA) and the scientific community at large could benefit from improved scientific tools and analytic techniques to undertake the complex scientific evaluation and decision making needed to make essential medical countermeasures available. At the request of FDA, the Institute of Medicine (IOM) held a workshop to examine methods to improve the development, evaluation, approval, and regulation of medical countermeasures. During public health emergencies such as influenza or chemical, biological, radiological/nuclear (CBRN) attacks, safe and effective vaccines, treatments, and other medical countermeasures are essential to protecting national security and the well being of the public. Advancing Regulatory Science for Medical Countermeasure Development examines current medical countermeasures, and investigates the future of research and development in this area. Convened on March 29-30, 2011, this workshop identified regulatory science tools and methods that are available or under development, as well as major gaps in currently available regulatory science tools. Advancing Regulatory Science for Medical Countermeasure Development is a valuable resource for federal agencies including the Food and Drug Administration (FDA), the Department of Health and Human Services (HHS), the Department of Defense (DoD), as well as health professionals, and public and private health organizations.
Author : United States. Congress. House. Committee on Homeland Security. Subcommittee on Emerging Threats, Cybersecurity, and Science and Technology
Publisher : Unknown
Page : 120 pages
File Size : 42,5 Mb
Release : 2009
Category : Medical
ISBN : UOM:39015090377774
Author : Institute of Medicine,Board on Health Sciences Policy,Forum on Medical and Public Health Preparedness for Catastrophic Events
Publisher : National Academies Press
Page : 95 pages
File Size : 54,7 Mb
Release : 2010-12-16
Category : Medical
ISBN : 9780309186506
During public health emergencies such as terrorist attacks or influenza outbreaks, the public health system's ability to save lives could depend on dispensing medical countermeasures such as antibiotics, antiviral medications, and vaccines to a large number of people in a short amount of time. The IOM's Forum on Medical and Public Health Preparedness for Catastrophic Events held a workshop on November 18, 2009, to provide an overview of current threats, recent progress made in the public health system for distributing and dispensing countermeasures, and remaining vulnerabilities.
Author : U.s. Government Accountability Office
Publisher : Createspace Independent Publishing Platform
Page : 44 pages
File Size : 48,6 Mb
Release : 2017-08-04
Category : Electronic
ISBN : 1974233618
" The nation remains vulnerable to terrorist and other threats posed by CBRN agents. Medical countermeasures-drugs, vaccines, and medical devices-can prevent or treat the effects of exposure to CBRN agents, and countermeasures are available in the SNS for some of these agents. Children, who make up 25 percent of the population in the United States, are especially vulnerable because many of the countermeasures in the SNS have only been approved for use in adults. HHS leads the federal efforts to develop and acquire countermeasures. GAO was asked about efforts to address the needs of children in the event of a CBRN incident. This report examines (1) the percentage of CBRN medical countermeasures in the SNS that are approved for pediatric use; (2) the challenges HHS faces in developing and acquiring CBRN medical countermeasures for the pediatric population, and the steps it is taking to address them; and (3) the ways that HHS has addressed the dispensing of pediatric medical countermeasures in its emergency response plans and guidance, and ways that state and local governments have addressed this issue. To address these objectives, GAO reviewed relevant laws, agency documents, and reports, and interviewed HHS officials, industry representatives, and subject-matter experts. GAO also reviewed a stratified sample of emergency response plans from seven state and seven local governments, based"
Author : National Research Council,Institute of Medicine,Board on Life Sciences,Medical Follow-up Agency,Committee on Accelerating the Research, Development, and Acquisition of Medical Countermeasures Against Biological Warfare Agents
Publisher : National Academies Press
Page : 160 pages
File Size : 54,6 Mb
Release : 2004-04-06
Category : Political Science
ISBN : 9780309166515
In recent years, substantial efforts have been initiated to develop new drugs, vaccines, and other medical interventions against biological agents that could be used in bioterrorist attacks against civilian populations. According to a new congressionally mandated report from the Institute of Medicine and National Research Council of the National Academies, to successfully develop these drugs, vaccines, and other medical interventions against biowarfare agents, Congress should authorize the creation of a new agency within the Office of the Secretary of the U.S. Department of Defense. The committee recommended that Congress should improve liability protections for those who develop and manufacture these products, to stimulate willingness to invest in new research and development for biowarfare protection. Giving Full Measure to Countermeasures also identifies other challengesâ€"such as the need for appropriate animal models and laboratories equipped with high-level biosafety protectionsâ€"that will require attention if DoD efforts to develop new medical countermeasures are to be successful.
Author : National Academies of Sciences, Engineering, and Medicine,Institute of Medicine,Board on Global Health,Board on Health Sciences Policy,Forum on Microbial Threats,Forum on Drug Discovery, Development, and Translation,Forum on Medical and Public Health Preparedness for Catastrophic Events
Publisher : National Academies Press
Page : 177 pages
File Size : 42,6 Mb
Release : 2016-03-12
Category : Medical
ISBN : 9780309378611
Emerging infectious disease threats that may not have available treatments or vaccines can directly affect the security of the world's health since these diseases also know no boundaries and will easily cross borders. Sustaining public and private investment in the development of medical countermeasures (MCMs) before an emerging infectious disease becomes a public health emergency in the United States has been extremely challenging. Interest and momentum peak during a crisis and wane between events, and there is little interest in disease threats outside the United States until they impact people stateside. On March 26 and 27, 2015, the Institute of Medicine convened a workshop in Washington, DC to discuss how to achieve rapid and nimble MCM capability for new and emerging threats. Public- and private-sector stakeholders examined recent efforts to prepare for and respond to outbreaks of Ebola Virus Disease, pandemic influenza, and coronaviruses from policy, budget, and operational standpoints. Participants discussed the need for rapid access to MCM to ensure national security and considered strategies and business models that could enhance stakeholder interest and investment in sustainable response capabilities. This report summarizes the presentations and discussions from this workshop.
Author : William O. Jenkins,Marcia Crosse
Publisher : DIANE Publishing
Page : 35 pages
File Size : 43,6 Mb
Release : 2011
Category : Political Science
ISBN : 9781437988000
Author : Anonim
Publisher : Unknown
Page : 1200 pages
File Size : 54,6 Mb
Release : 2009
Category : Electronic
ISBN : UOM:39015085443342
Author : United States. Congress. House. Committee on Appropriations. Subcommittee on Homeland Security
Publisher : Unknown
Page : 1708 pages
File Size : 41,8 Mb
Release : 2008
Category : National security
ISBN : SRLF:AX0002049419
Author : Anonim
Publisher : Unknown
Page : 1708 pages
File Size : 53,9 Mb
Release : 2008
Category : Electronic
ISBN : UOM:39015085443292